Media Inquiries: For all MAVA media inquiries, please contact us at 703-506-9300 or email firstname.lastname@example.org.
Check back regularly for news, coverage, and announcements about MAVA.
Lumena Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, announced that it has secured $45 million in Series B financing.
Signal Hill, a independent advisory boutique serving the M&A and private capital raising needs of growth companies, is pleased to announce that Eric Edmondson, co-founder of Seven Hills Partners, a highly-regarded San Francisco-based independent investment banking advisory firm, has joined the firm as a Managing Director in its San Francisco office.
Niara, a stealthy enterprise security company, has raised $9 million in funding from Index and NEA, we’re hearing from sources.
A new incubator focused on design and consumer startups is expected to land in Midtown Atlanta and the ambitious $200 million redevelopment plan stands as an example for how an incubator can tranform an entire neighborhood.
Cyber, Enterprise, Cloud, Education, Digital Media are Among Sectors Represented
Rehabtics, a health IT company in Baltimore, is looking to change the way patients think about physical therapy.
In-Q-Tel, the Arlington-based venture fund backed by the CIA, said it has invested in Canada's Redlen Technologies as part of that company's new $5.5 million funding round.
LLR Partners announces the final closing of LLR Equity Partners IV, L.P. (“LLR 4”), a $950 million private equity fund that builds on the firm’s 15-year history of investing in and partnering with middle market growth companies.
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that it has closed a $30 million non-dilutive loan transaction with Oxford Finance LLC ("Oxford").